serine/threonine Kinase 17a (STK17A) (N-Term) Peptid
STK17A
Reaktivität: Human
BP
Sodium azide
Produktnummer ABIN1382030
-
-
Target
Alle STK17A Produkte
-
STK17A
(serine/threonine Kinase 17a (STK17A))
-
Protein Region
-
N-Term
-
Spezies
-
Human
-
Applikation
-
Blocking Peptide (BP)
-
Produktmerkmale
-
15 amino amino terminus of human DRAK1.
Human
-
-
-
Applikationshinweise
-
DRAK1 peptide is used for blocking the activity of DRAK1.
-
Beschränkungen
-
Nur für Forschungszwecke einsetzbar
-
-
Format
-
Liquid
-
Konzentration
-
200 μg/mL
-
Buffer
-
PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1 % bovine serum albumin and 0.02 % sodium azide
-
Konservierungsmittel
-
Sodium azide
-
Vorsichtsmaßnahmen
-
This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
-
-20 °C
-
Haltbarkeit
-
12 months
-
-
Target
-
STK17A
(serine/threonine Kinase 17a (STK17A))
-
Synonyme
-
STK17A Peptide, DRAK1 Peptide, RDRAK1 Peptide, serine/threonine kinase 17a Peptide, serine/threonine kinase 17a L homeolog Peptide, STK17A Peptide, stk17a Peptide, stk17a.L Peptide
-